Update: CARB-X Grants Antabio Additional €4M to Develop Cystic Fibrosis Antibiotic
Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second…
Check out the latest antibiotic resistance news and antimicrobial resistance news. This section covers the latest biotech advancements to tackle antibiotic resistance.
Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second…
An antibiotic candidate developed by the Irish company Iterum Therapeutics has failed to meet the…
Amidst recent listeria outbreaks in Europe, the European Court of Justice has issued a court…
The Austrian biotech company PhagoMed Biopharma is developing a viral protein that could one day…
The UK biotech Procarta Biosystems has received a grant worth up to €8.3M from the…
The German biotech Curetis has been combined with the US genomics company OpGen to pool…
The US FDA has approved Nabriva Therapeutics’ Xenleta for treating community-acquired bacterial pneumonia, the first…
The Swiss biotech Polyphor has discontinued two phase III trials of its antibiotic for treating…
Belgian researchers have developed a potential treatment for anthrax that breaks down the bacteria’s thick…
The Bill and Melinda Gates Foundation has granted the German biotech Evotec €21M ($23.8M) to…
The Finnish biotech Mobidiag has received a loan of €25M from the European Investment Bank…
Polyphor has temporarily halted two phase III trials of an antibiotic treating pneumonia, after an…